Heart transplantation in AL amyloidosis

References

• Kyle R A, Gertz M A. Primary systemic amyloidosis: clinical and laboratory features in 474 cases. Seminars in Hematology 1995; 32: 45–59
   PubMed Web of Science ®Google Scholar
• Falk R H. Cardiac amyloidosis. Progress in Cardiology 1989; 2: 143–155
   Google Scholar
• Kyle R A, Greipp P R. Amyloidosis (AL): Clinical and laboratory features in 229 cases. Mayo Clin Proc 1983; 58: 665–683
   PubMed Web of Science ®Google Scholar
• Cueto-Garcia L, Reeder G S, Kyle R A, Wood D L, Seward J B, Naessens J, Offord K P, Greipp P R, Edwards W D, Tajik A J. Echocardiographic findings in systemic amyloidosis: spectrum of cardiac involvement and relation to survival. J Am Coll Cardiol 1985; 6: 737–743
   PubMed Web of Science ®Google Scholar
• Gertz M A, Kyle R A, Greipp P R. Response rates and survival in primary systemic amyloidosis. Blood 1991; 77: 257–262
   PubMed Web of Science ®Google Scholar
• Skinner M, Anderson J, Wang M, Simms R, Falk R, Jones L A, Cohen A S. Treatment of patients with primary amyloidosis. Amyloid and Amyloidosis, R Kisilevsky, M D Benson, B Frangione, J Gauldie, T J Muckle, I D Young. Parthenon, New York 1994; 232–234
   Google Scholar
• Comenzo R L, Simms R W, Samacki D L, Vosburgh E, Skinner M. Primary amyloidosis: feasibility of high-dose melphalan with mobilized blood stem-cell support. Blood 1994; 84S: 706a
   Google Scholar
• Van Buren M, Hene R J, Verdonck L F, Verzijlbergen F J, Lokhorst H M. Clinical remission after syngeneic bone marrow transplantation in a patient with AL amyloidosis. Ann Int Med 1995; 122: 508–510
   PubMed Web of Science ®Google Scholar
• Barnard C N. A human cardiac transplant: an interim report of a successful operation performed at Groote Shuur Hospital, Capetown. S Afr Med J 1967; 41: 1271–1274
   PubMedGoogle Scholar
• Hosenpud J D, Novick R J, Breen T J, Daily O P. The Registry of the International Society for Heart and Lung Transplantation: eleventh official report – 1994. J Heart Lung Transplant 1994; 13: 561–570
   PubMed Web of Science ®Google Scholar
• Fuster V, Gersh B J, Giuliani E R, Tajik A J, Brandenburg R O, Frye R L. Natural history of idiopathic dilated cardiomyopathy. Am J Cardiol 1981; 47: 525–531
   PubMed Web of Science ®Google Scholar
• Franciosa J A, Wilen M, Ziesche S, Cohn J N. Survival in men with severe chronic left ventricular failure due to either coronary heart disease or idiopathic dilated cardiomyopathy. Am J Cardiol 1983; 51: 831–836
   PubMed Web of Science ®Google Scholar
• McKee P A, Castelli W P, McNamara P M, Kannel W B. The natural history of congestive heart failure: the Framingham Study. New Engl J Med 1971; 285: 1441–1446
   PubMedGoogle Scholar
• Wilson J R, Schwartz J S, Sutton M SJ, Ferraro N, Horowitz L N, Reichek N, Josephson M E. Prognosis in severe heart failure: relation to hemodynamic measurements and ventricular ectopic activity. J Am Coll Cardiol 1983; 2: 403–410
   PubMed Web of Science ®Google Scholar
• Cohn J N, Levine T B, Olivari M T, Garberg V, Lura D, Francis G S, Simon A B, Rector T. Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. New Engl J Med 1984; 311: 819–823
   PubMed Web of Science ®Google Scholar
• Kannel W B, Belanger A F. Epidemiology of heart failure. Am Heart J 1991; 121: 951–957
   PubMed Web of Science ®Google Scholar
• Bourassa M G, Gurne O, Bangdiwala S I, Ghali J K, Young J B, Rousseau M, Johnstone D E, Yusuf S. Natural history and patterns of current practice in heart failure. J Am Coll Cardiol 1993; 22(Sup A)14A–9A
   Google Scholar
• Hosenpud J D, DeMarco T, Frazier H, Griffith B P, Uretsky B F, Menkis A H, O'Connell J B, Olivari M T, Valantine H A. Progression of systemic disease and reduced long term survival in patients with cardiac amyloidosis undergoing heart transplantation. Circulation 1991; 84, Suppl III, III 338-III 343
   Google Scholar
• Dubrey S, Simms R W, Skinner M, Falk R H. Recurrence of primary (AL) amyloidosis in a transplanted heart with 4 year survival. Am J Cardiol 1995; 76: 739–741
   PubMed Web of Science ®Google Scholar
• Valantine H A, Billingham M E. Recurrence of amyloid in a cardiac allograft four months after transplantation. J Heart Transplantation 1989; 8: 337–341
   Google Scholar
• Hall R, Hawkins P N. Cardiac transplantation for AL amyloidosis; good quality of life is possible for several years. Br Med J 1994; 309: 1135–1137
   PubMedGoogle Scholar
• Edwards B S, Hunt S A, Fowler M B, Valantine H A, Stinson E B, Schroeder J S. Cardiac transplantation in patients with preexisting neoplastic diseases. Am J Cardiol 1990; 65: 501–504
   Google Scholar
• Goldstein D J, Seldomridge J A, Addonizio L, Rose E A, Oz M C, Michler R E. Orthotopic heart transplantation in patients with treated malignancies. Am J Cardiol 1995; 75: 968–971
   Web of Science ®Google Scholar
• Copeland J G, Emery R W, Levinson M M, Icenogle T B, Carrier M, Ott R A, Copeland J A, McAleer-Rhenman M J, Nicholson S M. Transplantation of the heart: selection of patients for cardiac transplantation. Circulation 1987; 75: 2–9
   PubMed Web of Science ®Google Scholar
• Kubo S H, Ormaza S M, Francis G S, Holmer S C, Olivari M T, Bolman R M, III, Shumway S J. Trends in patient selection for heart transplantation. J Am Coll Cardiol 1993; 21: 975–981
   Google Scholar
• Simms R W, Prout M N, Cohen A S. The epidemiology of AL and AA amyloidosis. Balliere s Clinical Rheumatology 1994; 8: 627–634
   PubMed Web of Science ®Google Scholar
• Skinner M, Anderson J L, Simms R W, Falk R, Wang M, Libbey C A, Jones L A, Cohen A S. Treatment of 100 patients with AL amyloidosis: a randomized trial of melphalan, prednisone, and colchicine vs colchicine. Am J Med 1995, (in press)
   Google Scholar
• Miller L W. Candidate selection for heart transplantation. Cardiology Clinics 1995; 13: 93–99
   PubMedGoogle Scholar